Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment

被引:9
|
作者
Gjoni, Tina [1 ]
Urwyler, Stephan [1 ]
机构
[1] Novartis Inst Biomed Res, Basel, Switzerland
关键词
GABA(B) receptor; Constitutive activity; Inverse agonism; Allosteric modulator; Desensitization; Ligand property; Efficacy; PROTEIN-COUPLED RECEPTORS; MU-OPIOID-RECEPTOR; INVERSE AGONISTS; CONSTITUTIVE ACTIVITY; N,N'-DICYCLOPENTYL-2-METHYLSULFANYL-5-NITRO-PYRIMIDINE-4,6-DIAMINE GS39783; NEUTRAL ANTAGONISTS; HEPTAHELICAL DOMAIN; SIGNALING PROTEINS; POINT MUTATIONS; 2-STATE MODEL;
D O I
10.1016/j.ejphar.2008.12.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been estimated that only 15% of the compounds classified as silent G protein-coupled receptor antagonists are indeed devoid of either positive or negative intrinsic efficacy. Considering that 40% of all drugs on the market target G protein-coupled receptors mainly as orthosteric ligands, elucidating their intrinsic properties is becoming increasingly important. While agonism can be demonstrated using appropriately sensitive experimental setups, the detection of inverse agonism can be limited by a low degree of constitutive activity in many assay systems. In this study, changes in ligand behavior upon a lasting pretreatment with gamma-aminobutyric acid (GAB(B)), that induced receptor desensitization, were observed, measuring the second messenger cyclic AMP (cAMP) in a GABA(B) receptor-expressing recombinant cell line. The GABA(B) receptor partial agonist 2-OH-saclofen lost its ability to inhibit 7 beta-forskolin-induced cAMP production upon GAB(A)-pretreatment. The "silent" receptor antagonists CGP62349, CGP52432, CGP56999 and SCH50911, on the other hand, stimulated 7 beta-forskolin-induced cAMP production under these conditions. The inverse agonism of CGP56999 was inhibited by the efficacy-deficient 2-OH-saclofen, proving it was truly mediated through the orthosteric site of the GABA(B) receptor. Finally, the positive allosteric modulator GS39783, which previously only marginally inhibited cAMP production, suppressed it by 60% both alone and in the presence of the competitive receptor antagonist 2-OH-saclofen, thus GS39783 became an allosteric receptor agonist at desensitized GABA(B) receptors. These changes likely reflect adaptations in the mechanisms of GABA(B) receptor function following desensitization and may be important in the elucidation of intrinsic ligand efficacies as well as for the consequences of continuous drug treatment. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [21] Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder
    Colombo, Giancarlo
    ALCOHOL AND ALCOHOLISM, 2024, 59 (03):
  • [22] Pharmacological Characterization of the Allosteric Modulator Desformylflustrabromine and Its Interaction with α4β2 Neuronal Nicotinic Acetylcholine Receptor Orthosteric Ligands
    Weltzin, Maegan M.
    Schulte, Marvin K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03): : 917 - 926
  • [23] Critical role for the second extracellular loop in the binding of both orthosteric and allosteric g protein-coupled receptor Ligands
    Avlani, Vimesh A.
    Gregory, Karen J.
    Morton, Craig J.
    Parker, Michael W.
    Sexton, Patrick M.
    Christopoulos, Arthur
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (35) : 25677 - 25686
  • [24] PRECLINICAL EVIDENCE ON THE "ANTI-ALCOHOL" PROPERTIES OF THE POSITIVE ALLOSTERIC MODULATORS OF THE GABAB RECEPTOR
    Colombo, G.
    ALCOHOL AND ALCOHOLISM, 2013, 48 : 12 - 12
  • [25] Changes in GABAB receptor immunoreactivity after recurrent seizures in rats
    Kokaia, Z
    Kokaia, M
    NEUROSCIENCE LETTERS, 2001, 315 (1-2) : 85 - 88
  • [26] Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry
    Whitehurst, CE
    Nazef, N
    Annis, DA
    Hou, YM
    Murphy, DM
    Spacciapoli, P
    Yao, ZP
    Ziebell, MR
    Cheng, CC
    Shipps, GW
    Flesch, JS
    Lau, D
    Nash, HM
    JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (02) : 194 - 207
  • [27] α4β2*neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain
    Nirogi, Ramakrishna
    Goura, Venkatesh
    Abraham, Renny
    Jayarajan, Pradeep
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 712 (1-3) : 22 - 29
  • [28] Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist
    Pandey, Pankaj
    Roy, Kuldeep K.
    Doerksen, Robert J.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (01): : 32 - 47
  • [29] Reverse Engineering of the Selective Agonist TBPB Unveils Both Orthosteric and Allosteric Modes of Action at the M1 Muscarinic Acetylcholine Receptor
    Keov, Peter
    Valant, Celine
    Devine, Shane M.
    Lane, J. Robert
    Scammells, Peter J.
    Sexton, Patrick M.
    Christopoulos, Arthur
    MOLECULAR PHARMACOLOGY, 2013, 84 (03) : 425 - 437
  • [30] Profile of changes in gene expression in cultured hippocampal neurones evoked by the GABAB receptor agonist baclofen
    Ghorbel, MT
    Becker, KG
    Henley, JM
    PHYSIOLOGICAL GENOMICS, 2005, 22 (01) : 93 - 98